|
Post by kc on Dec 22, 2017 19:07:46 GMT -5
Oops. In @ 2.45. I guess my 12 steps starts again Tuesday. Same buy in cost
|
|
|
Post by kc on Dec 22, 2017 14:56:20 GMT -5
Temptation almost got me today. I have been on the 10 step program for years with MannKind. Temptation just got the best of me. 10 Step program failed. But hopefully MannKind will not let me fail.
|
|
|
Post by kc on Dec 22, 2017 14:54:21 GMT -5
I need to follow my 10 step MannKind addiction program. But It's Christmas and I needed one last gift for my stocking for 2017.
|
|
|
Post by kc on Dec 22, 2017 14:37:20 GMT -5
Borrowing rate is rising at Fidelity. CALL NOW!
|
|
|
Post by kc on Dec 22, 2017 14:25:32 GMT -5
Is that Afrezza on my screen
|
|
|
Post by kc on Dec 22, 2017 14:24:42 GMT -5
Tross paid $2.52? Ha, a loser like the rest of us! Mazel Tov!
I see either snow flakes or Afrezza powder on my screen.
|
|
|
Post by kc on Dec 22, 2017 0:27:57 GMT -5
A Chief People Officer putting up $100k of his own cash is an even stronger sign of good things quietly being discussed behind the curtain than the CEO putting up a lessor amount. No way to spin this as anything other than positive but no doubt some will try. Onward and Upward MNKD! Stuart’s purchase is better then a lump of coal for Christmas.
|
|
|
Post by kc on Dec 21, 2017 21:53:31 GMT -5
|
|
|
Post by kc on Dec 20, 2017 12:35:57 GMT -5
True..... He could also be David Kliff
|
|
|
Post by kc on Dec 20, 2017 12:08:39 GMT -5
Feroldi deletes posts, Osborne doesn't unless truly obscene is posted. Is he LFD?
|
|
|
Post by kc on Dec 20, 2017 12:07:54 GMT -5
Let's hope that the first week or two of 2018 there is something monumental ahead.
|
|
|
Post by kc on Dec 20, 2017 11:40:55 GMT -5
You can bet that Mike is working the insurance market very hard. He knows the drill. It takes time. It takes Patients pushing for Afrezza and that will come with the social media effect from advertising and patient awareness. Old doctors don't like changes from the same old same old. They have been wined and dined by the big three cartel companies. We have little to offer the old doctors other than great outcomes for their patients using Afrezza.
|
|
|
Post by kc on Dec 20, 2017 11:37:05 GMT -5
Slow bleed this time of year is folks harvesting losses and gains. I suspect that 1/2/2018 we see upwards momentum.
|
|
|
Post by kc on Dec 20, 2017 11:35:28 GMT -5
KC, Have you asked SA for the reason your post has been deleted? I'd push hard to get that info. If it's someone reporting it I'd want to know who. If it's one of our "friends' I'd raise a stink by going to a publication to do an investigative report. I'd try to blow the lid off all these creatures and I'd make sure it got shouted from the roof tops. After all, the way to make cockroaches scurry is to turn on the lights, figuratively speaking. Go get em !!! Its either LFD or Spencer Osburn. I don't really care and very rarely post there anymore. I view them like the IHUB board. 90% get's deleted so why post there.
|
|
|
Post by kc on Dec 20, 2017 11:33:39 GMT -5
Is it possible that allowing the share price to depreciate would somehow work in MNKD's favor? For example, by allowing short interest to accumulate further, would a short squeeze boost share price to a higher level than if the share price prior to the squeeze was higher? This is just one possible explanation. I'm curious as to how this will play out and I'm wondering what sort of strategy is being employed. The 140M authorized shares is, in my mind, a big wild card, so anything can happen. It may seem paradoxical, but perhaps under some circumstances, a depressed share price might actually be strength for the company. Are there historical examples of such cases? Find a good international partner who invests in the company for 15% or 20% at $20.00 and you would have an explosion that would destroy all the shorts. Something is up. Mike C. is very silent these days. Kent Kresa didn't buy at $6.00 to lose and he had to talk a good game to get somebody to invest in the other 60 Million in shares at $6.00.
Let's hope there is a serious game changer in the first quarter.
Advertising results won't really be seen or known til about April 1, 2018. It takes that long for patients to get into the DR and get a new product.
|
|